Skip to ContentSkip to Navigation
Over onsFaculty of Science and EngineeringOnderzoekGRIPPharmacoTherapy, -Epidemiology & -Economics (PTEE)Publications

Publications 2016

Below our publications are listed using several headings. Scientific publications relate to original research, often published internationally, but also in the Dutch language. Professional publications are in Dutch and relate to reviews and expressions of opinions.

Scientific publication international
1 Alsaad N, Dijkstra JA, Akkerman OW, de Lange WC, van Soolingen D, Kosterink JG, van der Werf TS, Alffenaar JW.Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of Tuberculosis. Antimicrob Agents Chemother. 2016 Jun 20;60(7):3942-7
2 Antoñanzas F, Terkola R, Postma MJ.The Value of Medicines: A Crucial but Vague Concept. Pharmacoeconomics. 2016 Dec;34(12):1227-39
3

Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, Schuiling-Veninga CCM, Wijlaars L, Zito JM, Hoffmann F. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. European Neuropsychopharmacology 2016;26(3):411-19

4

Beinema MJ, van der Meer FJM, Brouwers JRBJ, Rosendaal FR. Optimization of vitamin K antagonist drug dose finding by replacement of the international normalized ratio by a bidirectional factor : validation of a new algorithm. Journal of Thrombosis and Haemostasis 2016;14(3):479-84

5

Berm, EJJ, de Looff M, Wilffert B, Boersma C, Annemans L, Vegter S, van Boven J, Postma MJ. Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests : A Systematic Review. Second Update of the Literature. PLoS ONE 2016;11(1):e0146262

6 Berm EJJ, Odigie B, Bijlsma MJ, Wilffert B, Touw DJ, Maring JG.A clinical validation study for application of DBS in therapeutic drug monitoring of antidepressants. Bioanalysis 2016
7

Berm E, Kok R, Hak E, Wilffert B. Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry. Pharmacopsychiatry 2016 Apr 21. [Epub ahead of print]

8 Berm EJJ, Gout-Zwart JJ, Luttjeboer J, Wilffert B, Postma MJ. A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy. PLoS ONE 2016:11(12): e0169065
9 Bigaeva E, van Doorn E, Liu H, Hak E. Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability. PLoS One. 2016 May 5;11(5):e0154757. doi: 10.1371/journal.pone.0154757. eCollection 2016
10 Bijlsma MJ, Janssen F, Hak E. Estimating time-varying drug adherence using electronic records : extending the proportion of days covered (PDC) method. Pharmcoepidemiology and Drug Safety 2016;25(3):325-32
11 Bijlsma MJ, Vansteelandt S, Janssen F, Hak E. The effect of adherence to statin therapy on cardiovascular mortality: quantification of unmeasured bias using falsification end-points. BMC Public Health 2016 Apr 11;16:303. doi: 10.1186/s12889-016-2986-0
12 Bindels J, Ramaekers B, Ramos IC, Mohseninejad L, Knies S, Grutters J, Postma MJ, Al M, Feenstra T, Joore M. Use of Value of Information in Healthcare Decision Making : Exploring Multiple Perspectives. Pharmacoeconomics 2016;34(3):315-22
13 Blommestein HM, de Groot S, Aarts MJ, Vemer P, de Vries R, van Abeelen AF, Posthuma EF, Uyl-de Groot CA. Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands. Leuk Res. 2016 Sep 3;50:37-45. doi: 10.1016/j.leukres.2016.09.005. [Epub ahead of print]
14 Boland MR, van Boven JF, Kruis AL, Chavannes NH, van der Molen T, Goossens LM, Rutten-van Mölken MP. Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence. Respir Med. 2016 Jan;110:34-45. doi: 10.1016/j.rmed.2015.11.008. Epub 2015 Nov 23
15 Bolhuis MS, Tiberi S, Sotgiu G, De Lorenzo S, Kosterink JG, van der Werf TS, Migliori GB, Alffenaar, J-W. Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis? European Respiratory Journal 2016;47(4): 1288-90
16 Cao Q, Buskens E, Feenstra T, Jaarsma T, Hillege H, Postmus D. Continuous-Time Semi-Markov Models in Health Economic Decision Making: An Illustrative Example in Heart Failure Disease Management. Med Decis Making. 2016 Jan;36(1):59-71. doi: 10.1177/0272989X15593080. Epub 2015 Jul 14
17 Charlton RA, Klungsøyr K, Neville AJ, Jordan S, Pierini A, de Jong-van den Berg LT, Bos HJ, Puccini A, Engeland A, Gini R, Davies G, Thayer D, Hansen AV, Morgan M, Wang H, McGrogan A, Nybo Andersen AM, Dolk H, Garne E. Prescribing of Antidiabetic Medicines before, during and after Pregnancy: A Study in Seven European Regions. PLoS One. 2016 May 18;11(5):e0155737. doi: 10.1371/journal.pone.0155737. eCollection 2016
18 Charlton RA, Pierini A, Klungsøyr K, Neville AJ, Jordan S, de Jong-van den Berg LT, Thayer D, Bos HJ, Puccini A, Hansen AV, Gini R, Engeland A, Nybo Andersen AM, Dolk H, Garne E. Asthma medication prescribing before, during and after pregnancy: a study in seven European regions. BMJ Open. 2016 Jan 19;6(1):e009237. doi: 10.1136/bmjopen-2015-009237
19 Connolly MP, Tashjian C, Kotsopoulos N, Bhatt A, Postma MJ. A comparison of average wages with age-specific wages for assessing indirect productivity losses: analytic simplicity versus analytic precision. Eur J Health Econ. 2016 Jul 14. [Epub ahead of print]
20 Cragg L, Williams S, Chavannes NH , FRESH AIR Group (Postma MJ) . FRESH AIR: an implementation research project funded through Horizon 2020 exploring the prevention, diagnosis and treatment of chronic respiratory diseases in low-resource settings . npj Primary Care Respiratory Medicine 2016 ; 26 : 16035. DOI: 10.1038/npjpcrm.2016.35
21 Daud ANA, Bergman JEH, Kerstjens-Frederikse WS, Groen H , Wilffert B . The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key? International Journal of Molecular Sciences 2016:1 7 ( 8 ) DOI: 10.3390/ijms17081333
22 de Boer PT, Frederix GW, Feenstra TL, Vemer P. Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer. Pharmacoeconomics 2016 Apr 29. [Epub ahead of print]
23 de Boer PT, Crépey P, Pitman RJ, Macabeo B, Chit A, Postma MJ. Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States. Value Health. 2016 Dec;19(8):964-975. doi: 10.1016/j.jval.2016.05.012. Epub 2016 Jul 15
24 de Gier JJ & World Health Organization. Drug use and road safety: a policy brief . WHO Press. 2016:1-15
25 de Jong J, Garne E, de Jong-van den Berg LT, Wang H. The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review. Drugs Real World Outcomes 2016 May 24;3(2):131-143. eCollection 2016
26 de Jong J, Garne E, Wender-Ozegowska E, Morgan M, de Jong-van den Berg LT, Wang H. Insulin analogues in pregnancy and specific congenital anomalies: a literature review. Diabetes Metab Res Rev. 2016 May;32(4):366-75. doi: 10.1002/dmrr.2730. Epub 2015 Nov 6
27 de Jong L, Härmark L, van Puijenbroek E. Time course, outcome and management of adverse drug reactions associated with metformin from patient's perspective : a prospective, observational cohort study in the Netherlands. European Journal of Clinical Pharmacology 2016:1-8
28 de Vries FM, Voorham J, Hak E, Denig P. Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: a descriptive study. Int J Clin Pract. 2016 Jun;70(6):482-92. doi: 10.1111/ijcp.12806. Epub 2016 Apr 29
29 de Vries YA, de Jonge P, Kalverdijk L, Bos HJ, Schuiling-Veninga, CCM, Hak E. Poor guideline adherence in the initiation of antidepressant treatment in children and adolescents in the Netherlands : choice of antidepressant and dose. European Child & Adolescent Psychiatry 2016:1-10
30

Dijkstra BAG, Kamal R, van Noorden MS, de Haan H, Loonen AJM, de Jong CAJ. Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project. Drug and Alcohol Dependence. 2016 Nov 21;170:164-173. Available from, DOI: 10.1016/j.drugalcdep.2016.11.014

31 Dik J-WH, Dinkelacker AD, Vemer P, Lo-Ten-Foe JR, Lokate M, Sinha B, Friedrich AW, Postma MJ. Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital. PLoS ONE 2016;11(2):e0149226
32 Dik JW, Sinha B, Friedrich AW, Lo-Ten-Foe JR, Hendrix R, Köck R, Bijker B, Postma MJ, Freitag MH, Glaeske G, Hoffmann F. Cross-border comparison of antibiotic prescriptions among children and adolescents between the north of the Netherlands and the north-west of Germany. Antimicrob Resist Infect Control. 2016 Apr 18;5:14. doi: 10.1186/s13756-016-0113-8. eCollection 2016
33 Dik JW, Hendrix R, Poelman R, Niesters HG, Postma MJ, Sinha B, Friedrich AW. Measuring the impact of antimicrobial stewardship programs. Expert Rev Anti Infect Ther. 2016 Jun;14(6):569-75. doi: 10.1080/14787210.2016.1178064. Epub 2016 May 3
34 Dik JH, Sinha B, Lokate M, Lo-Ten-Foe JR, Dinkelacker AG, Postma MJ, Friedrich AW. Positive impact of infection prevention on the management of nosocomial outbreaks at an academic hospital. Future Microbiol. 2016 Oct;11:1249-1259. Epub 2016 Apr 11
35 Dolk H, Wang H, Loane M, Morris J, Garne E, Addor MC, Arriola L, Bakker M, Barisic I, Doray B, Gatt M, Kallen K, Khoshnood B, Klungsoyr K, Lahesmaa-Korpinen AM, Latos-Bielenska A, Mejnartowicz JP, Nelen V, Neville A, O'Mahony M, Pierini A, Rißmann A, Tucker D, Wellesley D, Wiesel A, de Jong-van den Berg LT. Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies. Neurology. 2016 May 3;86(18):1716-25. doi: 10.1212/WNL.0000000000002540. Epub 2016 Apr 6
36 Dolk C, Eichner M, Welte R, Anastassopoulou A, van Bellinghen L-A, Poulsen Nautrup B, van Vlaenderen I, Schmidt-Ott R, Schwehm M, Postma MJ. Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model. Pharmacoeconomics, 19.09.2016
37 Dunlop WC, Mullins CD, Pirk O, Goeree R, Postma MJ, Enstone A, Heron L. BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles. Pharmacoeconomics. 2016 Oct;34(10):1051-65. doi: 10.1007/s40273-016-0427-7
38 Dvortsin E, Gout-Zwart J, Eijssen E-LM, van Brussel J, Postma MJ.Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer, Review of the Literature and a Case Study in Breast Cancer. PLoS ONE 2016;11(1): e0146551
39 Enclada Ventura MAE, van Wanrooy MJP, Span LFR, Rodgers MGG, van den Heuvel ER, Uges DRA, van der Werf TS, Kosterink JGW, Alffenaar JWC. Longitudinal analysis of the effect of inflammation on voriconazole trough concentrations. Antimicrobial Agents and Chemotherapy 2016
40

Fugel HJ, Nuijten M, Postma M, Redekop K. Economic Evaluation in Stratified Medicine: Methodological Issues and Challenges. Front Pharmacol . 2016 May 9;7:113. doi: 10.3389/fphar.2016.00113. eCollection 2016

41 Fugel HJ, Nuijten M, Postma MJ.Economic viability of Stratified Medicine concepts: An investor perspective on drivers and conditions that favour using Stratified Medicine approaches in a cost-contained healthcare environment. Biotechnol.2016 Dec 25;33(6):860-867. doi: 10.1016/j.nbt.2016.09.003. Epub 2016 Sep 21
42 Gareb B, Eissens AC, Kosterink JGW, Frijlink Hendrik W. Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease. European Journal of Pharmaceutics and Biopharmaceutics 2016
43 Geurts MM, Stewart RE, Brouwers JR, de Graeff PA, de Gier JJ. Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder. Int J Clin Pharm. 2016 Aug;38(4):808-15. doi: 10.1007/s11096-016-0281-x. Epub 2016 Apr 6
44 Ghimire S, Van't Boveneind-Vrubleuskaya N, Akkerman OW, de Lange WC, van Soolingen D, Kosterink JG, van der Werf TS, Wilffert B, Touw DJ, Alffenaar JW.Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB. J Antimicrob Chemother. 2016 Oct;71(10):2691-703
45 Given JE, Loane M, Luteijn JM, Morris JK, de Jong van den Berg LT, Garne E, Addor MC, Barisic I, de Walle H, Gatt M, Klungsoyr K, Khoshnood B, Latos-Bielenska A, Nelen V, Neville AJ, O'Mahony M, Pierini A, Tucker D, Wiesel A, Dolk H. EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations. Br J Clin Pharmacol. 2016 Mar 29. doi: 10.1111/bcp.12947. [Epub ahead of print]
46 Huang Y, Vemer P, Zhu J, Postma MJ, Chen W. Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data. PLoS One . 2016 Aug 29;11(8):e0159297. doi: 10.1371/journal.pone.0159297. eCollection 2016
47 Hummels H, Bertholee D, van der Meer D, Smit JP, Wilffert B , t er Horst P . The quality of lactation st udies including antipsychotics. European Journal of Clinical Pharmacology . 2016 DOI: 10.1007/s00228-016-2121-2
48 Ivanova SA, Loonen AJ, Bakker PR, Freidin MB, Ter Woerds NJ, Al Hadithy AF, Semke AV, Fedorenko OY, Brouwers JR, Bokhan NA, van Os J, van Harten PN, Wilffert B. Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations. SAGE Open Med. 2016 Apr 11;4:2050312116643673. doi: 10.1177/2050312116643673. eCollection 2016
49 Ivanova SA, Fedorenko OY, Freidin Maxim B, Alifirova VM, Zhukova NG, Zhukova IA, Al Hadithy A, Brouwers J, Bokhan NA, Wilffert B, Loonen A. Dissimilar mechanistic background of peripheral and orofacial hyperkinesia in patients with Parkinson’s disease and levodopa-induced dyskinesia. Physiology and Pharmacology 2016;19:216-21
50

Ivanova SA, Loonen AJM. Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected Finding. Parkinsons Disease 2016:1-5

51 Ivanova SA, Osmanova DZ, Freidin MB, Fedorenko OY, Boiko AS, Pozhidaev IV, Semke AV, Bokhan NA, Agarkov AA, Wilffert B, Loonen AJ. Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia. World J Biol Psychiatry. 2016 Sep 22:1-8. [Epub ahead of print]
52 Ivanova SA, Osmanova DZ, Boiko AS, Pozhidaev IV, Freidin MB, Fedorenko OY, Semke AV, Bokhan NA, Kornetova EG, Rakhmazova LD, Wilffert B, Loonen AJ. Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics. Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30473-X. doi: 10.1016/j.schres.2016.10.029. [Epub ahead of print]
53 Jacobs MS, Kaasenbrood F, Postma MJ, van Hulst M, Tieleman RG. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands. Europace. 2016 Oct 12. pii: euw285. [Epub ahead of print]
54 Jessurun N, van Marum R, Hermens W, van Puijenbroek E. Advanced Age and Female Sex As Risk Factors for High Anion Gap Metabolic Acidosis After a Drug Interaction Between Paracetamol and Flucloxacillin: A Case Series' Journal of the American Geriatrics Society. 2016 DOI: 10.1111/jgs.14332
55 Kamal RM, van Noorden MS, Franzek E, Dijkstra BAG, Loonen AJM, de Jong CAJ.The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance : A Review. Neuropsychobiology 2016;73(2):65-80
56 Kamal RM, Dijkstra BA, Loonen AJ, De Jong CA. The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome. J Addict Med. 2016 Jul-Aug;10(4):229-35
57 Lako IM, Taxis K, van den Heuvel ER, Leenaars CHC, Burger H, Wiersma D, Slooff CJ, Knegtering H, Bruggeman R. Altered emotional experiences attributed to antipsychotic medications - A potential link with estimated dopamine D2 receptor occupancy. Psychiatry Research 2016;236:9-14
58 Liu H, Frijlink HW, Huckriede A, van Doorn E, Schmidt E, Leroy O, Rimmelzwaan G, McCullough K, Whelan M, Hak E. Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project. Vaccine. 2016 Oct 25. pii: S0264-410X(16)30975-6. doi: 10.1016/j.vaccine.2016.10.040. [Epub ahead of print]
59 Loonen AJM, Ivanova SA. Circuits regulating pleasure and happiness in major depression. Medical Hypotheses 2016;87:14-21
60

Loonen AJM, Ivanova SA. Circuits Regulating Pleasure and Happiness-Mechanisms of Depression. Frontiers in Human Neuroscience. 2016;10:571. Available from, DOI: 10.3389/fnhum.2016.00571

61

Loonen AJM, Ivanova SA. Circuits Regulating Pleasure and Happiness: The Evolution of the Amygdalar-Hippocampal-Habenular Connectivity in Vertebrates. Frontiers in Neuroscience. 2016;10:539. Available from, DOI: 10.3389/fnins.2016.00539

62 Luteijn JM, Morris J, Morris EG, Given J, de Jong-van den Berg L, Addor MC, Bakker M, Barisic I, Gatt M, Klungsoyr K, Latos-Bielenska A, Lelong N, Nelen V, Neville A, O'Mahony M, Pierini A, Tucker D, de Walle H, Wiesel A, Loane M, Dolk H. EUROmediCAT signal detection: A systematic method for identifying potential teratogenic medication. Br J Clin Pharmacol. 2016 Jun 28. doi: 10.1111/bcp.13056. [Epub ahead of print]
63 Luttjeboer J, Setiawan D, Cao Q, Cahh Daemen T, Postma MJ. Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands. Vaccine. 2016 Nov 2. pii: S0264-410X(16)30935-5. doi: 10.1016/j.vaccine.2016.10.019. [Epub ahead of print]
64 Mafirakureva N, Dzingirai B, Postma MJ, van Hulst M, Khoza S. Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe. AIDS Care. 2016 Jul;28(7):904-12. doi: 10.1080/09540121.2016.1173639. Epub 2016 Apr 21
65 Mafirakureva N, Mapako T, Khoza S, Emmanuel JC, Marowa L, Mvere D, Postma MJ, van Hulst M. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe. Transfusion. 2016 Oct 2. doi: 10.1111/trf.13858. [Epub ahead of print]
66 Mafirakureva N, Nyoni H, Nkomo SZ, Jacob JS, Chikwereti R, Musekiwa Z, Khoza S, Mvere DA, Emmanuel JC, Postma MJ, van Hulst M. The costs of producing a unit of blood in Zimbabwe. Transfusion. 2016 Mar;56(3):628-36. doi: 10.1111/trf.13405. Epub 2015 Nov 23.
67 Mapako T, Janssen MP, Mvere DA, Emmanuel JC, Rusakaniko S, Postma MJ, van Hulst M. Impact of using different blood donor subpopulations and models on the estimation of transfusion transmission residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Zimbabwe. Transfusion 2016
68 Mapako T, Oei W, van Hulst M, Kretzschmar ME, Janssen MP. Modelling the risk of transfusion transmission from travelling donors. BMC Infect Dis. 2016 Apr 1;16:143. doi: 10.1186/s12879-016-1452-z.
69 Martono DP, Hak E, Lambers Heerspink H, Wilffert B , Denig P . Predictors of HbA1c levels in initial users of metformin . Current Medical Research and Opinion 2016: 1-39. DOI: 10.1080/03007995.2016.1227774
70 Maurer JM, Hofmana S, Schellekens RCA, Tonnis WF, Dubois AOT, Woerdenbag HJ, Hinrichs WLJ, Kosterink JGW, Frijlink HW.Development and potential application of an oral ColoPulse infliximab tablet with colon specific release : A feasibility study. International Journal of Pharmaceutics 2016
71 Mulder B, Groenhof F, Kocabas LI, Bos HJ, de Vries TW, Hak E, Schuiling-Veninga C.Identification of Dutch children diagnosed with atopic diseases using prescription data : a validation study. European Journal of Clinical Pharmacology; 72(1):73-82
72

Mulder B, Pouwels KB, Schuiling-Veninga CC, Bos HJ, De Vries TW, Jick SS, Hak E. Antibiotic use during pregnancy and asthma in preschool children: the influence of confounding. Clin Exp Allergy. 2016 May 9. doi: 10.1111/cea.12756. [Epub ahead of print]

73 Nguyen TP, Wright EP, Nguyen TT, Schuiling-Veninga CC, Bijlsma MJ, Nguyen TB, Postma MJ. Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam. PLoS One. 2016 May 18;11(5):e0155699. doi: 10.1371/journal.pone.0155699. eCollection 2016
74 Özyilmaz A, Boersma C, Visser ST, Postma MJ, de Jong-van den Berg LT, Lambers-Heerspink HJ, de Jong PE, Gansevoort RT.The association of albuminuria and high-sensitivity C-reactive protein with the efficacy of HMG-coenzyme A reductase inhibitors for cardiovascular event prevention. Eur J Prev Cardiol. 2016 May;23(8):847-55. doi: 10.1177/2047487315604310. Epub 2015 Sep 10
75 Pouwels KB, Mulder B, Hak E. Moderate concordance was found between case-only and parallel group designs in systematic comparison. Journal of Clinical Epidemiology 2016;71:18-24
76 Pouwels KB, Widyakusuma NN, Groenwold RH, Hak E. Quality of reporting of confounding remained suboptimal after the STROBE guideline. Journal of Clinical Epidemiology 2016;69:217-24
77 Pouwels KB, Voorham J, Hak E, Denig P. Identification of major cardiovascular events in patients with diabetes using primary care data. BMC Health Services Research 2016;16(1):110
78 Pouwels KB, Widyakusuma NN, Bos JH, Hak E. Association between statins and infections among patients with diabetes: a cohort and prescription sequence symmetry analysis. Pharmacoepidemiol Drug Saf. 2016 Jun 30. doi: 10.1002/pds.4052. [Epub ahead of print]
79 Pouwels KB, Bozdemir SE, Yegenoglu S, Celebi S, McIntosh ED, Unal S, Postma MJ, Hacimustafaoglu M. Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data. PLoS One. 2016 Sep 30;11(9):e0163567. doi: 10.1371/journal.pone.0163567
80 Pouwels KB, Hak E. Is Heterogeneity in the Effects of Statins on Infection Outcomes across Clinical Studies Due to Bias? Antimicrob Agents Chemother. 2016 Oct 21;60(11):7002-7003. doi: 10.1128/AAC.01839-16. Print 2016 Nov
81 Ramaekers BL, Riemsma R, Tomini F, van Asselt T, Deshpande S, Duffy S, Armstrong N, Severens JL, Kleijnen J, Joore MA.Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. Pharmacoeconomics. 2016 Aug 26. [Epub ahead of print]
82 Richardson JL, Stephens S, Thomas SH, Jamry-Dziurla A, de Jong-van den Berg L, Zetstra-van der Woude P, Laursen M, Hliva V, Mt-Isa S, Bourke A, Dreyer NA, Blackburn SC. An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. JMIR Public Health Surveill. 2016 Mar 18;2(1):e13. doi: 10.2196/publichealth.5366
83

Rolfes L, Kolfschoten J, van Hunsel F, van Puijenbroek E. The validity and reliability of a signal impact assessment tool. Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):815-9. doi: 10.1002/pds.4038. Epub 2016 May 19

84 Rolfes L, van Hunsel F, Taxis K, van Puijenbroek E. The Impact of Experiencing Adverse Drug Reactions on the Patient's Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. Drug Saf. 2016 Aug;39(8):769-76. doi: 10.1007/s40264-016-0422-0
85 Rolfes L, Kolfschoten J, van Hunsel F, Kooijman M , van Puijenbroek E . Actions in response to drug safety signals arising from a spontaneous reporting system: Retrospective study in The Netherlands . The International journal of risk & safety in medicine 2016; 28 ( 2 ): 115-23. DOI: 10.3233/JRS-160724
86 Rolfes L, van Hunsel F, van Puijenbroek E. Response to the validity and reliability of a signal impact assessment tool: statistical issue to avoid misinterpretation. Pharmacoepidemiol Drug Saf. 2016 Oct;25(10):1217. doi: 10.1002/pds.4084 Comment/Letter to the editor
87 Rours GI, Smith-Norowitz TA, Ditkowsky J, Hammerschlag MR, Verkooyen RP, de Groot R, Verbrugh HA, Postma MJ. Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women. Pathog Glob Health. 2016 Oct - Dec;110(7-8):292-302
88 Saktiawati AM, Sturkenboom MG, Stienstra Y, Subronto YW, Sumardi, Kosterink JG, van der Werf TS, Alffenaar JW.Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over  trial. J Antimicrob Chemother. 2016 Mar;71(3):703-10
89 Schievink B, Kröpelin T, Mulder S, Parving HH, Remuzzi G, Dwyer J, Vemer P, de Zeeuw D, Lambers Heerspink HJ.Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes.Diabetes Obes Metab. 2016 Jan;18(1):64-71. doi: 10.1111/dom.12583. Epub 2015 Nov 27
90 Schlander M, Garattini S, Kolominsky-Rabas P, Nord E, Persson U, Postma MJ, Richardson J, Simoens S, de Solà-Morales O, Tolley K, Toumi M. Determining the value of medical technologies to treat ultra-rare disorders: a consensus statement. J Mark Access Health Policy. 2016 Oct 27;4. doi: 10.3402/jmahp.v4.33039. eCollection 2016
91 Scholl JH, van Puijenbroek EP.The value of time-to-onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands. Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1361-1367. doi: 10.1002/pds.4115. Epub 2016 Sep 30
92 Schreuder N, Mamedova I, Jansman FG. Radiopharmaceuticals in acute porphyria. Clin Ther 2016;2239-47
93 Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rissmann R, Kramers C, Richir MC, van Puijenbroek EP, van Agtmael MA; Education Committee/Working Group Research in Education of the Dutch Society of Clinical Pharmacology and Biopharmacy (NVKF&B), Utrecht, The Netherlands. Pharmacovigilance Skills, Knowledge and Attitudes in our Future Doctors - A Nationwide Study in the Netherlands. Basic Clin Pharmacol Toxicol. 2016 Nov 24. doi: 10.1111/bcpt.12712. [Epub ahead of print]
94 Schwappach DL, Pfeiffer Y, Taxis K. Medication double-checking procedures in clinical practice: a cross-sectional survey of oncology nurses' experiences. BMJ Open. 2016 Jun 13;6(6):e011394. doi: 10.1136/bmjopen-2016-011394
95 Setiawan D, Dolk FC, Suwantika AA, Westra TA, WIlschut JC, Postma MJ. Cost-Utility Analysis of Human Papillomavirus Vaccination and Cervical Screening on Cervical Cancer Patient in Indonesia. Value in Health Regional Issues 2016;9:84-92
96 Setiawan D, Kotsopoulos N, Wilschut JC, Postma MJ , Connolly MP . Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic Approach . PLoS ONE 2016;1 1 ( 8 ): e0160707. DOI: 10.1371/journal.pone.0160707
97 Smit R, Postma MJ. Vaccines for tick-borne diseases and cost-effectiveness of vaccination : a public health challenge to reduce the diseases’ burden. Expert review of vaccines 2016;15(1):1-3
98 Simoons M, Mulder H, Risselada AJ, Wilmink FW, Schoevers R, Ruhé HG, van Roon EN. Medication Discrepancies at Outpatient Departments for Mood and Anxiety Disorders in the Netherlands: Risks and Clinical Relevance. J Clin Psychiatry. 2016 Nov;77(11):1511-1518. doi: 10.4088/JCP.15m10376
99 Stevanović J, Postma MJ, Le HH. Budget Impact of Increasing Market Share of Patient Self-Testing and Patient Self-Management in Anticoagulation. Value in Health 2016
100 Stevanović J, Pechlivanoglou P, Kampinga MA, Krabbe PFM, Postma MJ. Multivariate Meta-Analysis of Preference-Based Quality of Life Values in Coronary Heart Disease. PLoS ONE 2016;11(3):e0152030
101 Stevanović J, de Jong LA, Kappelhoff BS, Dvortsin EP, Voorhaar M, Postma MJ. Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands. PLoS One 2016 Oct 24;11(10):e0163550. doi: 10.1371/journal.pone.0163550. eCollection 2016
102 Sturkenboom MG, Akkerman OW, van Altena R, de Lange WC, Kosterink JG, van der Werf TS, Alffenaar JC.Dosage of isoniazid and rifampicin poorly predicts drug exposure in tuberculosis patients. Eur Respir J. 2016 Oct;48(4):1237-9
103 Taxis K, Kochen S, Wouters H, Boersma F, Jan Gerard M, Mulder H, Pavlovic J, Stevens G, Andrew M, Pont LG.Cross-national comparison of medication use in Australian and Dutch nursing homes. Age and Ageing 14-Dec-2016 [Epub ahead of print]
104 Ter Avest M, Veringa A, van den Heuvel ER, Kosterink JGW, Schölvinck EH, Tissing WJE, Alffenaar J-WC. The effect of inflammation on voriconazole trough concentrations in children. British Journal of Clinical Pharmacology, 09.11.2016
105 Ter Weele EJ, Terwisscha van Scheltinga AG, Linssen MD, Nagengast WB, Lindner I, Jorritsma-Smit A, de Vries EG, Kosterink JG, Lub-de Hooge MN.Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use. Eur J Pharm Biopharm. 2016 Jul;104:226-34
106 Tomini F, Prinzen F, van Asselt ADI.A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure. European Journal of Health Economics 2016 Special issue, 04.01.2016, p. 1-14
107 Ultsch B, Damm O, Beutels P, Bilcke J, Brueggenjuergen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma MJ, Salo H, Siebert U, Wasem J, Wichmann O. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks : A Consensus Framework from a European Vaccine Economics Community. Pharmacoeconomics 2016;34(3):227-44
108 van Boven JFM, Vemer P. Higher adherence during reimbursement of pharmacological smoking cessation treatments. Nicotine and Tobacco Research 2016;18(1):56-63
109 van Boven JFM, Stuurman-Bieze AGG, Hiddink EG, Postma MJ.Effects of targeting disease and medication management interventions towards patients with COPD. Current Medical Research and Opinion 2016;32(2):229-39
110 van Boven JF, Kocks JW, Postma MJ. Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands. Int J Chron Obstruct Pulmon Dis. 2016 Sep 19;11:2191-2201. eCollection 2016
111 van den Houten MML, Lauret GJ, Fakhry F, Fokkenrood HJP, van Asselt ADI, Hunink MGM,Teijink JAW.Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication . British journal of Surgery 2016 . DOI: 10.1002/bjs.10247
112 Van den Oever HL, van Dam M, van 't Riet E, Jansman FG.Clinical parameters that predict the need for medium or intensive care admission in intentional drug overdose patients: A retrospective cohort study. J Crit Care 2016;37;156-61
113 van der Burgt EPM, Sturkenboom MGG, Bolhuis MS, Akkerman OW, Kosterink JGW, de Lange WCM, Cobelens FGJ, van der Werf TS, Alffenaar J-WC.End TB with precision treatment! European Respiratory Journal 2016;47(2):680-2
114

van der Schans J, Vardar S, Çiçek R, Bos HJ, Hoekstra PJ, de Vries TW, Hak E. An explorative study of school performance and antipsychotic medication. BMC Psychiatry. 2016 Sep 21;16(1):1-8

115 van der Schans S, Goossens LM, Boland MR, Kocks JW, Postma MJ, van Boven JF, Rutten-van Mölken MP. Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations. Pharmacoeconomics. 2016 Sep 3. [Epub ahead of print]
116 van der Schans J, Pleiter JC, de Vries TW, Schuiling-Veninga CC, Bos JH, Hoekstra PJ, Hak E. Association between medication prescription for atopic diseases and attention-deficit/hyperactivity disorder. Ann Allergy Asthma Immunol. 2016 Aug;117(2):186-91. doi: 10.1016/j.anai.2016.05.025. Epub 2016 Jun 14
117 van der Voort PHJ, Wilffert B, van Roon EN, Uges DRA. 4-Aminopyridine as a life-saving treatment in calcium channel antagonist intoxication. The Netherlands Journal of Medicine 2016;74(6):276
118 van Heesch MM, van Asselt AD, Evers JL, van der Hoeven MA, Dumoulin JC, van Beijsterveldt CE, Bonsel GJ, Dykgraaf RH, van Goudoever JB, Koopman-Esseboom C, Nelen WL, Steiner K, Tamminga P, Tonch N, Torrance HL, Dirksen CD.Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF. Hum Reprod. 2016 Nov;31(11):2527-40
119 Van Maanen BM, de Boer PT, Dolk FCK, Friedrich AW, Wilschut JC, Pitman R, Postma MJ.Dynamic modelling approaches for the analysis of the cost-effectiveness of seasonal influenza control. Expert review of vaccines 2016:1-4. DOI: 10.1080/14760584.2016.1221347
120

Van Mierlo LD, Wouters H, Sikkes SA, Van der Flier WM, Prins ND, Bremer JA, Koene T, Van Hout HP. Screening for Mild Cognitive Impairment and Dementia with Automated, Anonymous Online and Telephone Cognitive Self-Tests. J Alzheimers Dis. 2016 Nov 29. [Epub ahead of print]

121 van Rijn SP, van Altena R Akkerman OW, van Soolingen D, van der LaanT, de Lange WCM, Kosterink JGW, van der Werf TS, Alffenaar J-WC.Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis. European Respiratory Journal 2016 ;47(4):1229-34
122 van Rooijen JM, de Munck L, Teeuwen GM, de Graaf JC, Jansman FG, Boers JE, Siesling S. Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: a population-based study focusing on the elderly. Anticancer Drugs. 2016 Feb;27(2):127-32. doi: 10.1097/CAD.0000000000000310
123

Van't Boveneind-Vrubleuskaya N, Daskapan A, Kosterink JG, van der Werf TS, van den Hof S, Alffenaar JC. Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting. PLoS One. 2016 Nov 10;11(11):e0166030. doi: 10.1371/journal.pone.0166030. eCollection 2016

124 van Voorn GAK, Vemer P, Hamerlijnck D, Ramos IC, Teunissen GJ, Al M, Feenstra TL. The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling. Appl Health Econ Health Policy. 2016 Apr;14(2):129-33. doi: 10.1007/s40258-015-0200-7
125 van Wanrooy MJP, Rodgers MGG, Span LFR, Zijlstra JG, Uges DRA, Kosterink JGW, van der Werf TS, Alffenaar JWC. Voriconazole therapeutic drug monitoring practices in the intensive care. Therapeutic Drug Monitoring 2016
126 van Welie S, Wijma L, Beerden T, van Doormaal J, Taxis K. Effect of warning symbols in combination with education on the frequency of erroneously crushing medication in nursing homes: an uncontrolled before and after study. BMJ Open. 2016 Aug 5;6(8):e012286. doi: 10.1136/bmjopen-2016-012286
127 van Wijhe M, McDonald SA, de Melker HE, Postma MJ, Wallinga Jacco.Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century : a historical analysis. Lancet Infectious Diseases 2016
128 Vemer P, Corro Ramos I, van Voorn GA, Al MJ, Feenstra TL. AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users. Pharmacoeconomics. 2016 Apr;34(4):349-61. doi: 10.1007/s40273-015-0327-2
129 Veringa A, Ter Avest M, Span LFR, van den Heuvel ER, Touw DJ, Zijlstra JG, Kosterink JGW, van der Werf TS, Alffenaar J-WC. Voriconazole metabolism is influenced by severe inflammation : a prospective study. Journal of Antimicrobial Chemotherapy, 06.09.2016
130 Wammes JJ, van den Akker-van Marle ME, Verkerk EW, van Dulmen SA, Westert GP, van Asselt AD, Kool RB.Identifying and prioritizing lower value services from Dutch specialist guidelines and a comparison with the UK do-not-do list. BMC Med. 2016 Nov 25;14(1):196
131 Warnders FJ, Waaijer SJH, Pool M, Lub-de Hooge MN, Friedrich M, Terwisscha van Scheltinga AGt, Deegen P, Stienen SK, Pieslor PC, Cheung HK, Kosterink JGW, de Vries EGE. Biodistribution and PET Imaging of Labeled Bispecific T Cell Engaging Antibody targeting EpCAM. Journal of Nuclear Medicine 2016
132 Weersink RA, Bouma M, Burger DM, Drenth JP, Hunfeld NG, Kranenborg M, Monster-Simons MH, van Putten SA, Metselaar HJ, Taxis K, Borgsteede SD.Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion. BMJ Open. 2016 Oct 12;6(10):e012991. doi: 10.1136/bmjopen-2016-012991
133 Wouters H, van der Meer H, Taxis K. Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies. Eur J Clin Pharmacol. 2016 Dec 1. [Epub ahead of print]
134 Wouters H, Van Dijk L, Geers HCJ, Winters NA, Van Geffen ECG, Stiggelbout AM, Bouvy ML. Understanding Statin Non-Adherence : Knowing Which Perceptions and Experiences Matter to Different Patients. PLoS ONE 2016;11(1): e0146272
135

Wouters H, Amin DF, Taxis K, Heerdink ER, Egberts AC, Gardarsdottir H. Associations Between Personality Traits and Adherence to Antidepressants Assessed Through Self-Report, Electronic Monitoring, and Pharmacy Dispensing Data: A Pilot Study. J Clin Psychopharmacol. 2016 Jul 21. [Epub ahead of print]

136

Wouters H, Baars JW, Schagen SB. Neurocognitive function of lymphoma patients after treatment with chemotherapy. Acta Oncol. 2016 Jun 22:1-5. [Epub ahead of print]

137

Yska JP, Gertsen S, Flapper G, Emous M, Wilffert B, van Roon EN. NSAID Use after Bariatric Surgery: a Randomized Controlled Intervention Study. Obes Surg. 2016 May 12. [Epub ahead of print]

139 Yska JP, van der Meer DH, Dreijer AR, Eilander W, Apers JA, Emous M, Totté ERE, Wilffert B, van Roon EN. Influence of bariatric surgery on the use of medication. Eur J Clin Pharmacol, 2016;72(2): 203-9
140 Zakiyah N, van Asselt A, Postma MJ. Ulipristal acetate for pre-operative treatment of moderate to severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis. J Med Econ. 2016 Oct 27:1-17. [Epub ahead of print]
141 Zakiyah N, van Asselt AD, Roijmans F, Postma MJ. Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries; A Systematic Review. PLoS One. 2016 Dec 19;11(12):e0168447. doi: 10.1371/journal.pone.0168447. eCollection 2016
142 Zuur MA, Bolhuis MS, Anthony R, den Hertog A, van der Laan T, Wilffert B, de Lange W, van Soolingen D, Alffenaar J-W C. Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis. Expert Opinion on Drug Metabolism & Toxicology 2016
Professional
1 Brouwers JRBJ, Roeters van Lennep JE, Maas AHEM. 'Rode gist rijst' als cholesterolverlager? ['Red yeast rice' as a cholesterol-lowering substance?Caution is warranted]. Nederlands tijdschrift voor geneeskunde 2016;160(0): D99
2 Brouwers JRBJ. Vloeibare vorm van alendronaat winst voor ouderen. Ins&ouds : informatie- en mededelingenperiodiek van de Nederlandse Vereniging voor Klinische Geriatrie 2016:3-6
3

Brouwers JRBJ, Jansen PAF. IJzertherapie bij ouderen: een update. MFM-Tijdschrift over praktijkgerichte farmacotherapie. 2016;1:32-6

4

Brouwers JRBJ, Siersema PD. IJzergebreksanemie en ijzersuppletie: nieuwe inzichten. Modern Medicine 2016;1:4-8

5 Brouwers JRBJ, Wolffenbuttel B. Levothyroxine-substitutie: de kunst van het doseren in optima farma. Modern Medicine 2016;5:130-34
6 de Vries LC, de Swart IW, van Puijenbroek EP. [The Teratology Information Service: medicines during pregnancy and lactation]. Nederlands tijdschrift voor geneeskunde 2016;160(0):A9900
7 Jansen PAF, Noppe-Hamerpagt D, Brouwers JRBJ, Knol W, van Roon EN. Terughoudendheid geboden in gebruik NOAC’s bij kwetsbare ouderen. Pharm Weekbl 2016;38:10-2
8

Loonen AJM. Opzet en vrije wil bij delicten door een psychische stoornis. Nederlands Juristenblad 2016;14:919-23

9 Mouch I, Brouwers JRBJ, van 't Riet E, Nieboer P, Otten MH, Jansman FG. [5-HT3-antagonists as a substitute for metoclopramide and domperidone: a literature review]. [Article in Dutch] Ned Tijdschr Geneeskd. 2016;160(0):A9887
10 Van Leeuwen RWF, Jansman FGA, Van Gelder T, Mathijssen RH. Bijna 30% van oncologische patiënten heeft een interactie. Wisselwerking belangrijke factor bij individualisering kankerbehandeling. Pharm Weekbl 2016; 151(36):20-1
11 Van Ojik AL, Hemmelder M, Hoogendoorn M, Folkeringa R, Smit R, Derijks HJ, Hofma SH, Van Roon EN. Anti-Xa-activiteit van therapeutisch nadrparine bij verminderde nierfunctie en behandeling conform richtlijn Nederlandse federatie voor nefrologie: vergelijking met dtandaarddosis bij normale nierfunctie. Pharm Weekbl NPFO 2016;1:19-22
12 Weersink RA, Borgsteede SD, Okel E, Pras N, van Putten AW. Het gebruik van paracetamol bij patiënten met levercirrose en het risico op hepatotoxiciteit.Nederlands Platform voor Farmaceutisch Onderzoek 2016;1:a1606
13 Wetzelaer P, Lokkerbol J, Arntz A, van Asselt A, Evers S. Kosteneffectiviteit van psychotherapie voor persoonlijkheidsstoornissen; een systematisch literatuuronderzoek van economische evaluatiestudies [Cost-effectiveness of psychotherapy for personality disorders.A systematic review on economic evaluation studies]. Tijdschr Psychiatr. 2016;58(10):717-27 (Article in Dutch)
14

Wilffert B. Dosering nadroparine bij nachtelijke hemodialyse. Nederlands Platform voor Farmaceutisch Onderzoek 2016;1: 37

15

Wilffert B. Toxiciteit van ftuorpyrimidines bij drie varianten van dihydropyrimidinedehydrogenase. Pharmaceutisch Weekblad 2016;e1610

16 Yska JP, van Roon EN. Het gebruik van antidepressiva na een bariatrische operatie. PsyFar 2016;11:54-8
Book (chapter)
1

Loonen AJM, Schellekens AFA, Ivanova SA. Circuits Regulating Pleasure and Happiness: A Focus on Addiction, Beyond the Ventral Striatum. In: Recent Advances in Drug Addiction Research and Clinical Applications. Meil WM & Ruby CL (eds.) 14-Jul-2016

2

Loonen AJM, Ivanova SA. Circuits Regulating Pleasure and Happiness in Schizophrenia: The Neurobiological Mechanism of Delusions. In Schizophrenia Treatment - The New Facets. InTech. 2016. p. 109-134

Laatst gewijzigd:14 maart 2017 09:31